Glaxosmithkline | Eiendeler

Assets Endring Dato
AbbVie USD 148.87B 12.65B 2024-03
Amgen USD 92.98B 4.17B 2024-03
AstraZeneca USD 102.29B 1.17B 2024-03
Aurora Cannabis CAD 817.17M 1.2M 2023-12
Bausch Health Companies USD 26.91B 437M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Canopy Growth CAD 1.3B 59.42M 2024-03
Catalent USD 9.88B 109M 2024-03
Corcept Therapeutics USD 655.94M 34.42M 2024-03
Drreddys Laboratories INR 372.84B 25.82B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
Glaxosmithkline GBP 58.51B 494M 2024-03
J&J USD 171.97B 5.9B 2024-03
Merck USD 105.85B 878M 2024-03
Novartis USD 94.33B 5.61B 2024-03
Pacira USD 1.58B 8.93M 2024-03
Perrigo USD 10.64B 168.8M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Prestige Brands USD 3.32B 21.34M 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
Supernus Pharmaceuticals USD 1.3B 26.42M 2024-03
Takeda JPY 14.22T 648.94B 2023-12
Teva Pharmaceutical Industries USD 42.77B 706M 2024-03
Zoetis USD 14.35B 62M 2024-03



Glaxosmithkline Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.